Show Notes
To access all episodes plus 150+ hours of advanced psychiatric education join the Academy today. Get access here: https://www.academy.psychscene.com/
Why is Alzheimer’s disease more common in women? In this episode, we break down what current research reveals about sex differences in Alzheimer’s biology — including hormonal changes, tau progression, genetics, and how women often compensate on early cognitive testing, delaying diagnosis.
We also discuss how these differences shape clinical assessment, treatment responses to emerging anti-amyloid therapies, and why midlife risk modification is especially important.
Key Points Women show faster tau accumulation once amyloid appears. Cognitive compensation can lead to later diagnosis in women. Estrogen decline at menopause influences inflammation, synaptic resilience, and neuroprotection. APOE-ε4 confers greater Alzheimer’s risk in women. Sex-specific risk factors require tailored prevention and assessment. To access all episodes plus 150+ hours of advanced psychiatric education join the Academy today. Get access here: https://www.academy.psychscene.com/
More from Thinking In Psychiatry
View the mentioned paper here: Memantine to Treat Social Impairment in Youths With Autism Spectrum Disorder https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2839518 Access the mentioned course here: Understanding Autism Spectrum Disorder: A Comprehensive Guide to Clinical Assessment & Diagnosis https://psychscene.co/4zXOHNW In this video, Dr Sanil Rege examines a 2025 randomised controlled trial of memantine for social impairment in young people with Autism Spectrum Disorder (ASD).
Access mentioned course here: Advanced Psychiatric Formulation and Strategic Management Masterclass https://psychscene.co/3Rn0Sm3 Here is the link to the paper mentioned: Towards a Consensus Roadmap for a New Diagnostic Framework for Mental Disorders https://www.sciencedirect.com/science/article/pii/S0924977X24007168 In this episode, Dr Sanil Rege examines a 2025 ECNP consensus roadmap calling for psychiatry to move beyond descriptive diagnosis towards biology-informed, transdiagnostic, and mechanism-based models. He explores how circuit biomarkers, inflammation, genomic overlap, digital phenotyping, and machine learning may refine patient stratification, treatment selection, and relapse prediction across traditional diagnostic boundaries. This video provides clinicians with a neurobiological framework for shifting from label-based treatment to mechanism-informed formulation in psychiatric practice.
Here are the links to the papers mentioned: Parkinson’s disease as a somato-cognitive action network disorder Ren et. al.
Access the mentioned courses here: Sleep And Psychiatry: